v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 16,955 $ 10,770 $ 30,517 $ 19,918
General and administrative 6,369 5,816 12,436 10,792
Total operating expenses 23,324 16,586 42,953 30,710
Income (Loss) from operations (23,324) (16,586) (42,953) (30,710)
Other income (expense), net:        
Interest and investment income (expense) 1,656 1,626 3,503 3,355
Other income (expense) 481
Other income (expense), net 1,656 1,626 3,503 3,836
Net income (loss) (21,668) (14,960) (39,450) (26,874)
Other comprehensive income (loss):        
Net unrealized gain (loss) on marketable debt securities 1 (12) (453) 75
Other comprehensive income (loss) 1 (12) (453) 75
Comprehensive income (loss) $ (21,667) $ (14,972) $ (39,903) $ (26,799)
Net income (loss) per share attributable to common stockholders, basic (in Dollars per share) $ (0.36) $ (0.35) $ (0.67) $ (0.65)
Net income (loss) per share attributable to common stockholders, diluted (in Dollars per share) $ (0.36) $ (0.35) $ (0.67) $ (0.65)
Weighted-average shares outstanding, basic (in Shares) 61,006,766 42,270,855 59,282,380 41,493,714
Weighted-average shares outstanding, diluted (in Shares) 61,006,766 42,270,855 59,282,380 41,493,714